Works matching IS 03057453 AND DT 2025 AND VI 80 AND IP 2
Results: 39
Correction to: Characterisation of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 605, doi. 10.1093/jac/dkae474
- By:
- Publication type:
- Article
Critical assessment of commercially available microtitre panels for antimicrobial susceptibility testing of veterinary pathogens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 319, doi. 10.1093/jac/dkae471
- By:
- Publication type:
- Article
Comparison of ChromID<sup>®</sup> and CHROMagar<sup>™</sup> media in a real workflow for detecting EBSL and carbapenemase-producing Enterobacterales.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 595, doi. 10.1093/jac/dkae463
- By:
- Publication type:
- Article
Co-occurrence of the cephalosporinase cepA and carbapenemase cfiA genes in a Bacteroides fragilis division II strain, an unexpected finding—authors' response.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 600, doi. 10.1093/jac/dkae460
- By:
- Publication type:
- Article
A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 334, doi. 10.1093/jac/dkae451
- By:
- Publication type:
- Article
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022–23)
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 583, doi. 10.1093/jac/dkae450
- By:
- Publication type:
- Article
Temocillin efficacy against AmpC β-lactamase-producing Enterobacterales: a relevant alternative to cefepime?
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 576, doi. 10.1093/jac/dkae449
- By:
- Publication type:
- Article
Distinct molecular epidemiology of resistances to extended-spectrum cephalosporins and carbapenems in Enterobacter hormaechei in cats and dogs versus horses in France.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 567, doi. 10.1093/jac/dkae448
- By:
- Publication type:
- Article
Novel approach using automated target enrichment enables culture-independent accurate whole-genome sequencing of Neisseria gonorrhoeae directly from clinical urogenital and extragenital specimens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 563, doi. 10.1093/jac/dkae446
- By:
- Publication type:
- Article
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 593, doi. 10.1093/jac/dkae445
- By:
- Publication type:
- Article
Simulated achievement rate of β-lactams/nacubactam treatment in humans using instantaneous MIC-based PK/PD analysis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 547, doi. 10.1093/jac/dkae443
- By:
- Publication type:
- Article
Efficacy of nintedanib as a host-directed therapy candidate in the treatment of tuberculosis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 452, doi. 10.1093/jac/dkae429
- By:
- Publication type:
- Article
Treatment success prediction in patients with methicillin-resistant coagulase-negative staphylococci infections, using vancomycin AUC<sub>24</sub>/MIC ratio: a multicentre retrospective cohort study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 538, doi. 10.1093/jac/dkae442
- By:
- Publication type:
- Article
Characterization of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 445, doi. 10.1093/jac/dkae428
- By:
- Publication type:
- Article
Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home–acquired urinary tract infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 472, doi. 10.1093/jac/dkae431
- By:
- Publication type:
- Article
Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 554, doi. 10.1093/jac/dkae444
- By:
- Publication type:
- Article
Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 518, doi. 10.1093/jac/dkae440
- By:
- Publication type:
- Article
Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 465, doi. 10.1093/jac/dkae430
- By:
- Publication type:
- Article
Investigation on the reversal effect of closantel on colistin resistance in MCR-1 positive Escherichia coli based on dose–response relationship.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 528, doi. 10.1093/jac/dkae441
- By:
- Publication type:
- Article
Repurposing zidovudine and 5-fluoro-2′-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity–reducing agent uridine.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 509, doi. 10.1093/jac/dkae438
- By:
- Publication type:
- Article
Side effects associated with itraconazole therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 503, doi. 10.1093/jac/dkae437
- By:
- Publication type:
- Article
Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 496, doi. 10.1093/jac/dkae436
- By:
- Publication type:
- Article
Comment on: prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 603, doi. 10.1093/jac/dkae435
- By:
- Publication type:
- Article
Importin α inhibitors act against the differentiated stages of apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 485, doi. 10.1093/jac/dkae434
- By:
- Publication type:
- Article
Development and confirmation of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin in a standardized neutropenic murine pneumonia model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 478, doi. 10.1093/jac/dkae432
- By:
- Publication type:
- Article
Comment on: Co-occurrence of the cephalosporinase cepA and carbapenemase cfiA genes in a Bacteroides fragilis Division II strain: an unexpected finding.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 598, doi. 10.1093/jac/dkae427
- By:
- Publication type:
- Article
Comparative evaluation of eravacycline susceptibility testing methods in 587 clinical carbapenem-resistant Acinetobacter baumannii isolates: broth microdilution, MIC test strip and disc diffusion.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 439, doi. 10.1093/jac/dkae426
- By:
- Publication type:
- Article
Synergistic antimicrobial activity of lynronne-1 and EDTA against bovine mastitis pathogens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 427, doi. 10.1093/jac/dkae425
- By:
- Publication type:
- Article
Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 413, doi. 10.1093/jac/dkae424
- By:
- Publication type:
- Article
Efficacy and tolerability of high-dose cefalexin 45 mg/kg/dose (maximum 1.5 g) three times daily in children with bone and joint infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 409, doi. 10.1093/jac/dkae423
- By:
- Publication type:
- Article
Effect of empiric antibiotics against Pseudomonas aeruginosa on mortality in hospitalized patients: a systematic review and meta-analysis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 322, doi. 10.1093/jac/dkae422
- By:
- Publication type:
- Article
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 405, doi. 10.1093/jac/dkae420
- By:
- Publication type:
- Article
A case of penicillin-resistant group B Streptococcus isolated from a patient in the UK.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 399, doi. 10.1093/jac/dkae419
- By:
- Publication type:
- Article
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 386, doi. 10.1093/jac/dkae416
- By:
- Publication type:
- Article
Establishment of epidemiological cut-off values of etimicin: a new fourth-generation aminoglycoside, against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Acinetobacter baumannii and Staphylococcus aureus.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 381, doi. 10.1093/jac/dkae414
- By:
- Publication type:
- Article
Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 372, doi. 10.1093/jac/dkae413
- By:
- Publication type:
- Article
Parenteral aciclovir for suspected herpes simplex virus infection in children: 0–18 years.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 354, doi. 10.1093/jac/dkae411
- By:
- Publication type:
- Article
Insights into interspecies protein binding variability using clindamycin as an example.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 363, doi. 10.1093/jac/dkae412
- By:
- Publication type:
- Article
Safety, tolerability and pharmacokinetics of subcutaneous cefazolin as an alternative to intravenous administration.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 347, doi. 10.1093/jac/dkae397
- By:
- Publication type:
- Article